Basf Aktiengesellschaft

Wolfgang Worstmann

Dieter Lenke

Hans J Treiber

Gerd Steiner

Josef Gries

Albrecht Franke

Hans-Juergen Teschendorf

Horst Kreiskott

Harald Weifenbach

Karl-Heinz Geiss

Walter-Wielant Wiersdorff

Rolf Kretzschmar

Hans-Joachim May

Hans-Juegen Teschendorf

1-Aroyl-2-phenylamino-2-imidazolines of the general formula ##STR1## where R.sup.1 and R.sup.2 are identical or different and each is chlorine, bromine, fluorine, methyl, ethyl, methoxy, trifluoromethyl or cyano,

1-Aroyl-2-phenylamino-2-imidazolines, drugs containing these compounds,

6-Substituted 11-alkylene-morphanthridines, also referred to as 11-alkylene-dibenzo[b,e]-azepines, their pure cis- and trans-isomers, processes for their preparation, and therapeutic agents containing these compounds, which may be used as drugs, in particular neuroleptics, sedatives, hypnotics, analgesics, antidepressants or agents for treating Parkinson's syndrome.

6(1-Piperazinyl), piperidino and (1(homopiperazinyl)11-cyanomethylene

1,4-Cycloalkano-oxazepines, salts thereof and analgesic uses thereof

Novel carbamates derived from substituted cyclic .beta.-keto-alcohols, their preparation, and pharmaceutical formulations which contain these compounds and which may be used as hypnotics in the treatment of sleep disturbance and as sedatives.

Novel carbamates, their preparation, and pharmaceutical formulations

Novel hexahydro-1,4-oxazepines of the general formula I ##STR1## where R.sup.1 is hydrogen, or alkyl or acyl each of 1 to 4 carbon atoms,

Hexahydro-1,4-oxazepines, their preparation, and drugs containing these

Growing community of inventors

Gruenstadt, Germany

Wolfgang Worstmann